Zai Lab ZLAB
NASDAQ ZLAB
$26.23 -0.77 (-2.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zai Lab (ZLAB) Share-based Compensation (2017 - 2026)

Zai Lab (ZLAB) posted Share-based Compensation of $13.5 million for Q1 2026, down 14.95% sequentially from $15.9 million in Q4 2025, and down 14.41% YoY from $15.8 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Share-based Compensation (2017 - 2026) Analysis & Trends

Zai Lab has reported Share-based Compensation for 10 years, with the latest figure at $13.5 million in Q1 2026.

  • Quarterly Share-based Compensation fell 14.41% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.3 million (down 7.52% YoY) and the FY2025 annual result came in at $65.6 million, down 7.15% from the prior year.
  • Share-based Compensation fell to $13.5 million in Q1 2026 per ZLAB's latest filing, from $15.9 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $22.0 million in Q3 2023 and troughed at $12.4 million in Q1 2022.
  • A 5-year average of $17.1 million and a median of $16.9 million in 2025 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2022 and 2024: Share-based Compensation jumped 81.02% in 2022, then retreated 23.63% in 2024.
  • Over 5 years, Share-based Compensation stood at $15.6 million in 2022, then surged by 31.56% to $20.5 million in 2023, then slipped by 15.79% to $17.2 million in 2024, then dropped by 7.75% to $15.9 million in 2025, then decreased by 14.95% to $13.5 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $13.5 million, $15.9 million, and $16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn 11.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.94 Mn
Mar 31, 2026 13.52 Mn
Dec 31, 2025 15.90 Mn
Sep 30, 2025 16.92 Mn
Jun 30, 2025 16.97 Mn
Mar 31, 2025 15.80 Mn
Dec 31, 2024 17.24 Mn
Sep 30, 2024 16.80 Mn
Jun 30, 2024 18.64 Mn
Mar 31, 2024 17.98 Mn
Dec 31, 2023 20.47 Mn
Sep 30, 2023 21.99 Mn
Jun 30, 2023 20.51 Mn
Mar 31, 2023 16.66 Mn
Dec 31, 2022 15.56 Mn
Sep 30, 2022 19.11 Mn
Jun 30, 2022 14.22 Mn
Mar 31, 2022 12.41 Mn
Dec 31, 2021 12.61 Mn
Sep 30, 2021 10.56 Mn